Literature DB >> 18679374

Neuropsychological outcome in very young hematopoietic SCT recipients in relation to pretransplant conditioning.

A-C Smedler1, J Winiarski.   

Abstract

Stem cell transplantation involves conditioning with TBI and/or intensive chemotherapy, which may cause long-term neuropsychological deficits, particularly in children treated at a very young age. The aim of this study was to investigate whether very young children who receive chemotherapy-based conditioning only (BUCY) may have a more favorable neuropsychological outcome than children conditioned with TBI-CY. Twenty-two children who underwent allogeneic SCT at 0.4-3.6 years of age were subject to an extensive neuropsychological assessment at an average of 6.5 years post-therapy. The test results of 10 children exposed to BU were compared to the results of 12 children who had received TBI. Ten of them had received single-dose TBI, whereas two had received fractionated TBI. The BU group performed at age level on verbal measures, but tended to score below age level in the executive and visuo-spatial domains (P<0.01). By comparison, children treated with TBI had more pervasive neuropsychological impairments, including motor deficits (P<0.01) and varying degrees of perceptual (P<0.05), executive and cognitive (P<0.05) problems. In conclusion, children transplanted at a very young age had a more favorable neuropsychological development if conditioned with BUCY than if conditioned with single-dose TBI-CY.

Entities:  

Mesh:

Year:  2008        PMID: 18679374     DOI: 10.1038/bmt.2008.217

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  14 in total

1.  Neurocognitive functioning in long-term survivors of pediatric hematopoietic cell transplantation.

Authors:  Kendra R Parris; Kathryn M Russell; Brandon M Triplett; Sean Phipps
Journal:  Bone Marrow Transplant       Date:  2020-11-14       Impact factor: 5.483

2.  Cognitive outcome after pediatric stem-cell transplantation: impact of age and total-body irradiation.

Authors:  Victoria W Willard; Wing Leung; Qinlei Huang; Hui Zhang; Sean Phipps
Journal:  J Clin Oncol       Date:  2014-11-10       Impact factor: 44.544

3.  NCI, NHLBI/PBMTC First International Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: health-related quality of life, functional, and neurocognitive outcomes.

Authors:  Susan K Parsons; Sean Phipps; Lillian Sung; K Scott Baker; Michael A Pulsipher; Kirsten K Ness
Journal:  Biol Blood Marrow Transplant       Date:  2011-12-10       Impact factor: 5.742

Review 4.  Neurocognitive Dysfunction in Hematopoietic Cell Transplant Recipients: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Complications and Quality of Life Working Party of the European Society for Blood and Marrow Transplantation.

Authors:  Debra Lynch Kelly; David Buchbinder; Rafael F Duarte; Jeffrey J Auletta; Neel Bhatt; Michael Byrne; Zachariah DeFilipp; Melissa Gabriel; Anuj Mahindra; Maxim Norkin; Helene Schoemans; Ami J Shah; Ibrahim Ahmed; Yoshiko Atsuta; Grzegorz W Basak; Sara Beattie; Sita Bhella; Christopher Bredeson; Nancy Bunin; Jignesh Dalal; Andrew Daly; James Gajewski; Robert Peter Gale; John Galvin; Mehdi Hamadani; Robert J Hayashi; Kehinde Adekola; Jason Law; Catherine J Lee; Jane Liesveld; Adriana K Malone; Arnon Nagler; Seema Naik; Taiga Nishihori; Susan K Parsons; Angela Scherwath; Hannah-Lise Schofield; Robert Soiffer; Jeff Szer; Ida Twist; Anne Warwick; Baldeep M Wirk; Jean Yi; Minoo Battiwalla; Mary E Flowers; Bipin Savani; Bronwen E Shaw
Journal:  Biol Blood Marrow Transplant       Date:  2017-09-20       Impact factor: 5.742

5.  Adverse health events and late mortality after pediatric allogeneic hematopoietic SCT-two decades of longitudinal follow-up.

Authors:  M Wilhelmsson; A Vatanen; B Borgström; B Gustafsson; M Taskinen; U M Saarinen-Pihkala; J Winiarski; K Jahnukainen
Journal:  Bone Marrow Transplant       Date:  2015-03-23       Impact factor: 5.483

6.  Relapsed acute lymphoblastic leukaemia after allogeneic stem cell transplantation: a therapeutic dilemma challenging the armamentarium of immunotherapies currently available (case reports).

Authors:  Fiona Poyer; Anna Füreder; Wolfgang Holter; Christina Peters; Heidrun Boztug; Michael Dworzak; Gernot Engstler; Waltraud Friesenbichler; Stefan Köhrer; Roswitha Lüftinger; Leila Ronceray; Volker Witt; Herbert Pichler; Andishe Attarbaschi
Journal:  Ther Adv Hematol       Date:  2022-05-23

7.  Incidence and severity of crucial late effects after allogeneic HSCT for malignancy under the age of 3 years: TBI is what really matters.

Authors:  D Bresters; A Lawitschka; C Cugno; U Pötschger; A Dalissier; G Michel; K Vettenranta; M Sundin; A Al-Seraihy; M Faraci; P Sedlacek; A B Versluys; A Jenkins; P Lutz; B Gibson; A Leiper; M A Diaz; P J Shaw; R Skinner; T A O'Brien; N Salooja; P Bader; C Peters
Journal:  Bone Marrow Transplant       Date:  2016-06-27       Impact factor: 5.483

Review 8.  Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT.

Authors:  David Buchbinder; Debra Lynch Kelly; Rafael F Duarte; Jeffery J Auletta; Neel Bhatt; Michael Byrne; Zachariah DeFilipp; Melissa Gabriel; Anuj Mahindra; Maxim Norkin; Helene Schoemans; Ami J Shah; Ibrahim Ahmed; Yoshiko Atsuta; Grzegorz W Basak; Sara Beattie; Sita Bhella; Christopher Bredeson; Nancy Bunin; Jignesh Dalal; Andrew Daly; James Gajewski; Robert Peter Gale; John Galvin; Mehdi Hamadani; Robert J Hayashi; Kehinde Adekola; Jason Law; Catherine J Lee; Jane Liesveld; Adriana K Malone; Arnon Nagler; Seema Naik; Taiga Nishihori; Susan K Parsons; Angela Scherwath; Hannah-Lise Schofield; Robert Soiffer; Jeff Szer; Ida Twist; Anne B Warwick; Baldeep M Wirk; Jean Yi; Minoo Battiwalla; Mary D E Flowers; Bipin Savani; Bronwen E Shaw
Journal:  Bone Marrow Transplant       Date:  2018-01-17       Impact factor: 5.483

9.  Late toxicity of a novel allogeneic stem cell transplant using single fraction total body irradiation for hematologic malignancies in children.

Authors:  Lisa M Madden; Alexander I Ngwube; Shalini Shenoy; Todd E Druley; Robert J Hayashi
Journal:  J Pediatr Hematol Oncol       Date:  2015-03       Impact factor: 1.289

Review 10.  Neurocognitive Impairment After Hematopoietic Stem Cell Transplant for Hematologic Malignancies: Phenotype and Mechanisms.

Authors:  Rebecca A Harrison; Noha Sharafeldin; Jennie L Rexer; Brennan Streck; Melissa Petersen; Ashley M Henneghan; Shelli R Kesler
Journal:  Oncologist       Date:  2021-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.